Chengdu Enwei Investment (Group) Co., Ltd.
Founded in 1986, Chengdu Enwei Group is a high-tech multinational enterprise integrating scientific research, production and trade, led by the technology industry expert Xue Yongxin, and led by Enwei people to work hard and work hard to manage. The group has more than 10 subsidiaries and 27 offices. It has a total of tens of billions of assets. The group's main body, Sichuan Enwei Pharmaceutical Co., Ltd., has registered capital of more than 110 million yuan, and currently has more than 3,000 employees, including 32 doctoral, postdoctoral, and senior engineers. Bachelor degree or above accounts for 58% of the total number of employees. It is a national designated postdoctoral fellow Mobile station. Benefit and power are "water", "benefit all things without fighting." The philosophical thoughts of Tao, Buddhism and Confucianism as the guide, established the corporate philosophy of "Wishing all living beings to be happy and social auspicious", "Serving society and benefiting mankind" as the corporate purpose, and Taoism The "inaction" idea is the corporate spirit, and it uses it to guide the business of the enterprise. In order to "save the world and benefit all living beings", Enwei chose the traditional Chinese medicine industry, combining the traditional Chinese medicine with 5,000 years of history with Chinese culture and modern medical technology, and establishing a Chinese-style and Chinese characteristics around life sciences. The pharmaceutical industry is to relieve the pain and troubles brought to human body and mind by modern diseases. For more than 20 years, Enwei Group has always adhered to its beliefs and purpose, experienced difficulties and twists and turns, and ushered in today's glory. Enwei Group has always adhered to market-oriented and consumer satisfaction as the core, established a commercial network of consumers → pharmacies → secondary dealers → first-level dealers → group headquarters, and established sales staff, The medical staff network, from pharmacies to patients, establishes family health records, performs the duties of a family physician, and serves patients. Enwei Group uses modern information and network technology to integrate the Internet and the group's local area network. Through the CRM system, it implements online reporting, approval, and all patient information, health consultation, commercial orders, salesperson market trends, plans, and expenses. Review. All information is collected into the group company through the Internet for the group to study and formulate scientific research, production and business strategies. Enwei Group closely combines corporate beliefs and market demand, formulates an industrial strategy for harmonious development between man and nature, invests in and establishes three pharmaceutical bases and packaging bases in Chengdu Hi-Tech Zone, Shuangliu and Haikou City, Hainan Province, and establishes in Sichuan Province. Three Chinese herbal medicine planting bases. Among them, according to the requirements of GAP, nearly 10,000 mu of precious Chinese medicinal materials bases are invested and built, and nearly 50,000 mu of the company's raw materials planting bases are invested and built, effectively ensuring the quantity and quality of raw materials. In order to serve the new drugs independently developed to all living beings, the group company introduced professional instruments and equipment from Europe and the United States, and made traditional Chinese medicine into dosage forms without adding any auxiliary materials during the production process to ensure the natural purity and quality of the drugs produced. At the same time, the company has integrated ISO9000 quality management system and GMP pharmaceutical specifications into production management since the early 1990s, and passed the certification to effectively ensure that product quality always maintains a high level with a scientific and standardized quality and production process management system. .
Chengdu Enwei Investment (Group) Co., Ltd.
Founded in 1986, Chengdu Enwei Group is a high-tech multinational enterprise integrating scientific research, production and trade, led by the technology industry expert Xue Yongxin, and led by Enwei people to work hard and work hard to manage. The group has more than 10 subsidiaries and 27 offices. It has a total of tens of billions of assets. The group's main body, Sichuan Enwei Pharmaceutical Co., Ltd., has registered capital of more than 110 million yuan, and currently has more than 3,000 employees, including 32 doctoral, postdoctoral, and senior engineers. Bachelor degree or above accounts for 58% of the total number of employees. It is a national designated postdoctoral fellow Mobile station. Benefit and power are "water", "benefit all things without fighting." The philosophical thoughts of Tao, Buddhism and Confucianism as the guide, established the corporate philosophy of "Wishing all living beings to be happy and social auspicious", "Serving society and benefiting mankind" as the corporate purpose, and Taoism The "inaction" idea is the corporate spirit, and it uses it to guide the business of the enterprise. In order to "save the world and benefit all living beings", Enwei chose the traditional Chinese medicine industry, combining the traditional Chinese medicine with 5,000 years of history with Chinese culture and modern medical technology, and establishing a Chinese-style and Chinese characteristics around life sciences. The pharmaceutical industry is to relieve the pain and troubles brought to human body and mind by modern diseases. For more than 20 years, Enwei Group has always adhered to its beliefs and purpose, experienced difficulties and twists and turns, and ushered in today's glory. Enwei Group has always adhered to market-oriented and consumer satisfaction as the core, established a commercial network of consumers → pharmacies → secondary dealers → first-level dealers → group headquarters, and established sales staff, The medical staff network, from pharmacies to patients, establishes family health records, performs the duties of a family physician, and serves patients. Enwei Group uses modern information and network technology to integrate the Internet and the group's local area network. Through the CRM system, it implements online reporting, approval, and all patient information, health consultation, commercial orders, salesperson market trends, plans, and expenses. Review. All information is collected into the group company through the Internet for the group to study and formulate scientific research, production and business strategies. Enwei Group closely combines corporate beliefs and market demand, formulates an industrial strategy for harmonious development between man and nature, invests in and establishes three pharmaceutical bases and packaging bases in Chengdu Hi-Tech Zone, Shuangliu and Haikou City, Hainan Province, and establishes in Sichuan Province. Three Chinese herbal medicine planting bases. Among them, according to the requirements of GAP, nearly 10,000 mu of precious Chinese medicinal materials bases are invested and built, and nearly 50,000 mu of the company's raw materials planting bases are invested and built, effectively ensuring the quantity and quality of raw materials. In order to serve the new drugs independently developed to all living beings, the group company introduced professional instruments and equipment from Europe and the United States, and made traditional Chinese medicine into dosage forms without adding any auxiliary materials during the production process to ensure the natural purity and quality of the drugs produced. At the same time, the company has integrated ISO9000 quality management system and GMP pharmaceutical specifications into production management since the early 1990s, and passed the certification to effectively ensure that product quality always maintains a high level with a scientific and standardized quality and production process management system. .
Shanghai Pharmaceuticals Holding Co., Ltd.
Shanghai Leiyunshang Pharmaceutical Co., Ltd. is a core Chinese patent medicine enterprise under Shanghai Pharmaceutical Group, and owns the Chinese time-honored brand "Lei's" brand founded in 1734. The company is mainly engaged in the research, development, production and sales of modern Chinese patent medicines and natural botanical medicines. Its main products include ginkgo ketone ester series, Liushen pills, Babu ointment series (joint analgesic Babu ointment), etc. In recent years, the company has worked hard to build a benchmark for the modern development of Shanghai's state-owned time-honored pharmaceutical companies, jointly promoted the industry-university-research cooperation and industrialization of classic famous hospital preparations with many well-known hospitals across the country, and undertaken the local production of Shanghai's traditional Chinese medicine formula granules. At the same time, the company combines modern technology with the advantageous resources of classic traditional Chinese medicine and modern technology, based on the company's own varieties and hospital experts' traditional Chinese medicine health prescription resources, seeking breakthroughs in the fields of health beverages, traditional Chinese medicine health tea and herbal medicine cosmetics, and developing cross-border joint fashion brands. Products, layout in the new retail field. Lei will adhere to the concept of "innovation-led, quality first, service first" inherited by time-honored brands, adhere to the core values of "innovation, integrity, cooperation, responsibility, and professionalism", and continue to develop the core business areas of professional medicine in the future, and deepen the cultivation of big health and Internet+ In the two innovative fields, we unswervingly implement the development strategy of "big products, big brands, big health", and strive to make Chinese people healthier and become the leader of excellent Chinese brand traditional Chinese medicine companies.
Shanghai Pharmaceuticals Holding Co., Ltd.
Shanghai Leiyunshang Pharmaceutical Co., Ltd. is a core Chinese patent medicine enterprise under Shanghai Pharmaceutical Group, and owns the Chinese time-honored brand "Lei's" brand founded in 1734. The company is mainly engaged in the research, development, production and sales of modern Chinese patent medicines and natural botanical medicines. Its main products include ginkgo ketone ester series, Liushen pills, Babu ointment series (joint analgesic Babu ointment), etc. In recent years, the company has worked hard to build a benchmark for the modern development of Shanghai's state-owned time-honored pharmaceutical companies, jointly promoted the industry-university-research cooperation and industrialization of classic famous hospital preparations with many well-known hospitals across the country, and undertaken the local production of Shanghai's traditional Chinese medicine formula granules. At the same time, the company combines modern technology with the advantageous resources of classic traditional Chinese medicine and modern technology, based on the company's own varieties and hospital experts' traditional Chinese medicine health prescription resources, seeking breakthroughs in the fields of health beverages, traditional Chinese medicine health tea and herbal medicine cosmetics, and developing cross-border joint fashion brands. Products, layout in the new retail field. Lei will adhere to the concept of "innovation-led, quality first, service first" inherited by time-honored brands, adhere to the core values of "innovation, integrity, cooperation, responsibility, and professionalism", and continue to develop the core business areas of professional medicine in the future, and deepen the cultivation of big health and Internet+ In the two innovative fields, we unswervingly implement the development strategy of "big products, big brands, big health", and strive to make Chinese people healthier and become the leader of excellent Chinese brand traditional Chinese medicine companies.
Anhui Huayuan Pharmaceutical Group Co., Ltd.
Anhui Huayuan Pharmaceutical Group Co., Ltd. is a modern pharmaceutical enterprise located in Taihe County, Anhui Province. The company was formerly known as Taihe County Pharmaceutical Company, and was established in 1953. In the early 1990s, the company was in debt of tens of millions of yuan and was on the verge of bankruptcy. After 1991, under the leadership of the new leadership team, we gradually embarked on a reversal path of survival through rectification and promoting development through standardization. At present, the company has more than 120 subsidiaries and tens of thousands of employees across the country. More than 400,000 square meters of modern warehouses are built, and the daily inventory of drugs is worth 3 billion yuan. More than 4,000 pharmaceutical manufacturers have more than 60,000 product specifications are distributed in the company, forming a business pattern of "buy nationwide, sell nationwide" and selling The market is hailed as the "barometer" of national pharmaceutical business. The company's development has driven the prosperity of many industries such as finance, communications, transportation, hotels, catering, and real estate in Taihe County. Tens of thousands of people are engaged in medicine and related industries, maintaining social stability and driving the local economy. In recent years, the company has actively contributed to the society and invested more than 50 million yuan in charity and public welfare. The company regulates the rescue of the market, establishes the city with quality, develops the city with integrity, and serves the city with more than 2,000 computers. It strictly controls the purchase of drugs, the acceptance of the warehouse, the storage and maintenance of the warehouse, the review of the warehouse, and the sales of the warehouse. At this time, a strict quality firewall has been built to ensure the quality of drugs and ensure the safety of the people’s medication. In recent years, the company has implemented the strategy of "both industrial and commercial development and two-wheel drive", relying on its commercial advantages, vigorously developing the pharmaceutical industry, and is affiliated with Shanghai Huayuan Anhui Renji Pharmaceutical, Ningxia Shasai Pharmaceutical, Anhui Jinhui Pharmaceutical, Anhui Guangsheng Pharmaceutical and other four. A pharmaceutical company has more than 200 varieties and nearly 300 specifications, including large-capacity injections, lyophilized powder injections, solid preparations, tablets, granules, pills, etc. Products sold nationwide. The company also vigorously develops the platform economy and has created multiple platforms such as logistics, exhibitions, e-commerce, health care product sales, and medical devices.
Anhui Huayuan Pharmaceutical Group Co., Ltd.
Anhui Huayuan Pharmaceutical Group Co., Ltd. is a modern pharmaceutical enterprise located in Taihe County, Anhui Province. The company was formerly known as Taihe County Pharmaceutical Company, and was established in 1953. In the early 1990s, the company was in debt of tens of millions of yuan and was on the verge of bankruptcy. After 1991, under the leadership of the new leadership team, we gradually embarked on a reversal path of survival through rectification and promoting development through standardization. At present, the company has more than 120 subsidiaries and tens of thousands of employees across the country. More than 400,000 square meters of modern warehouses are built, and the daily inventory of drugs is worth 3 billion yuan. More than 4,000 pharmaceutical manufacturers have more than 60,000 product specifications are distributed in the company, forming a business pattern of "buy nationwide, sell nationwide" and selling The market is hailed as the "barometer" of national pharmaceutical business. The company's development has driven the prosperity of many industries such as finance, communications, transportation, hotels, catering, and real estate in Taihe County. Tens of thousands of people are engaged in medicine and related industries, maintaining social stability and driving the local economy. In recent years, the company has actively contributed to the society and invested more than 50 million yuan in charity and public welfare. The company regulates the rescue of the market, establishes the city with quality, develops the city with integrity, and serves the city with more than 2,000 computers. It strictly controls the purchase of drugs, the acceptance of the warehouse, the storage and maintenance of the warehouse, the review of the warehouse, and the sales of the warehouse. At this time, a strict quality firewall has been built to ensure the quality of drugs and ensure the safety of the people’s medication. In recent years, the company has implemented the strategy of "both industrial and commercial development and two-wheel drive", relying on its commercial advantages, vigorously developing the pharmaceutical industry, and is affiliated with Shanghai Huayuan Anhui Renji Pharmaceutical, Ningxia Shasai Pharmaceutical, Anhui Jinhui Pharmaceutical, Anhui Guangsheng Pharmaceutical and other four. A pharmaceutical company has more than 200 varieties and nearly 300 specifications, including large-capacity injections, lyophilized powder injections, solid preparations, tablets, granules, pills, etc. Products sold nationwide. The company also vigorously develops the platform economy and has created multiple platforms such as logistics, exhibitions, e-commerce, health care product sales, and medical devices.
Taizhou Nanfeng Pharmaceutical Co., Ltd.
Taizhou Nanfeng Pharmaceutical Co., Ltd. (formerly Zhejiang Taizhou Pharmaceutical Factory) was established in October 1969 and established a new company through restructuring in September 1997. Since its establishment, it has gone through fifty years of development. The company is surrounded by mountains and rivers and has a reasonable layout. It is a Chinese patent medicine manufacturer that manufactures more than ten Chinese patent medicine forms such as tablets, hard capsules, granules, syrups, wines, and tinctures. There are 95 Chinese patent medicine products approved by Sinopharm, 52 products listed in the National Class A and Class B social security catalog, and 10 products listed in the new medical reform basic drug catalog.
Taizhou Nanfeng Pharmaceutical Co., Ltd.
Taizhou Nanfeng Pharmaceutical Co., Ltd. (formerly Zhejiang Taizhou Pharmaceutical Factory) was established in October 1969 and established a new company through restructuring in September 1997. Since its establishment, it has gone through fifty years of development. The company is surrounded by mountains and rivers and has a reasonable layout. It is a Chinese patent medicine manufacturer that manufactures more than ten Chinese patent medicine forms such as tablets, hard capsules, granules, syrups, wines, and tinctures. There are 95 Chinese patent medicine products approved by Sinopharm, 52 products listed in the National Class A and Class B social security catalog, and 10 products listed in the new medical reform basic drug catalog.
Peili Group is a leader in the Hong Kong concentrated traditional Chinese medicine formula granule product market. Since its establishment in 1998, the group has been committed to the internationalization and modernization of traditional Chinese medicine, and has worked with many international scholars to establish technology in the traditional Chinese medicine market. The status of pioneers. Through continuous innovation, Peili® has been known as the leader in product research and development, production technology and equipment, marketing planning, quality control and even basic scientific research. It has been widely recognized by the consumer and pharmaceutical industry. We have cultivated our efforts in Nanning, Guangxi, China and have established our own international modern Chinese medicine production and research base. Our production facilities not only comply with the GMP standards of the national production quality management standard, but also meet the TGA standard of the Australian Drug Administration, one of the internationally strict standards certifications. Peili’s own national standards laboratory has been certified by China’s National Accreditation Committee for Conformity Assessment (CNAS) according to ISO 17025. This is an international multilateral mutual certification system, making Peili® the most advanced traditional Chinese medicine research and production facilities in Asia. one. With its advanced development concepts and production technology, a series of traditional Chinese medicine health care retail products developed by Peili®, such as Jinlingizhi®, Angusheng®, Ufa Nong® and other brands, are very popular in Hong Kong and overseas markets. The ONCO-Z® ingredient of Angusheng® Medicinal Yunzhi, a subsidiary of the group, has been certified by the United States Pharmacopoeia Commission and is the earliest traditional Chinese medicine ingredient in the world to obtain the United States Pharmacopoeia (USP) certification. The US pharmacopoeia standard has been adopted by more than 140 countries around the world and is also recognized as one of the stricter quality control standards for evaluating the characteristics, efficacy, quality and purity of drugs. Peili® has obtained these international standards and is sufficient to prove its advanced production research technology and excellent quality. As modern people's awareness of health continues to improve, today's society's pursuit of health products and quality of life is becoming increasingly arduous. As a pioneer in the modernization and internationalization of traditional Chinese medicine, Peili® will continue to strive to provide high-quality products and create a longer, healthy and happy life for mankind with the wisdom of traditional Chinese medicine.
Pui Lik Holdings Limited
Peili Group is a leader in the Hong Kong concentrated traditional Chinese medicine formula granule product market. Since its establishment in 1998, the group has been committed to the internationalization and modernization of traditional Chinese medicine, and has worked with many international scholars to establish technology in the traditional Chinese medicine market. The status of pioneers. Through continuous innovation, Peili® has been known as the leader in product research and development, production technology and equipment, marketing planning, quality control and even basic scientific research. It has been widely recognized by the consumer and pharmaceutical industry. We have cultivated our efforts in Nanning, Guangxi, China and have established our own international modern Chinese medicine production and research base. Our production facilities not only comply with the GMP standards of the national production quality management standard, but also meet the TGA standard of the Australian Drug Administration, one of the internationally strict standards certifications. Peili’s own national standards laboratory has been certified by China’s National Accreditation Committee for Conformity Assessment (CNAS) according to ISO 17025. This is an international multilateral mutual certification system, making Peili® the most advanced traditional Chinese medicine research and production facilities in Asia. one. With its advanced development concepts and production technology, a series of traditional Chinese medicine health care retail products developed by Peili®, such as Jinlingizhi®, Angusheng®, Ufa Nong® and other brands, are very popular in Hong Kong and overseas markets. The ONCO-Z® ingredient of Angusheng® Medicinal Yunzhi, a subsidiary of the group, has been certified by the United States Pharmacopoeia Commission and is the earliest traditional Chinese medicine ingredient in the world to obtain the United States Pharmacopoeia (USP) certification. The US pharmacopoeia standard has been adopted by more than 140 countries around the world and is also recognized as one of the stricter quality control standards for evaluating the characteristics, efficacy, quality and purity of drugs. Peili® has obtained these international standards and is sufficient to prove its advanced production research technology and excellent quality. As modern people's awareness of health continues to improve, today's society's pursuit of health products and quality of life is becoming increasingly arduous. As a pioneer in the modernization and internationalization of traditional Chinese medicine, Peili® will continue to strive to provide high-quality products and create a longer, healthy and happy life for mankind with the wisdom of traditional Chinese medicine.
Jiangzhong Pharmaceutical Group Co., Ltd.
A leading Chinese pharmaceutical company producing traditional Chinese medicines.
Jiangzhong Pharmaceutical Group Co., Ltd.
A leading Chinese pharmaceutical company producing traditional Chinese medicines.
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Specializes in traditional Chinese medicine, including Zuo Gui Wan.
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Specializes in traditional Chinese medicine, including Zuo Gui Wan.
Tasly Pharmaceutical Group Co., Ltd.
A major Chinese pharmaceutical company known for its traditional Chinese medicine products.
Tasly Pharmaceutical Group Co., Ltd.
A major Chinese pharmaceutical company known for its traditional Chinese medicine products.
China Shineway Pharmaceutical Group Limited
A leading Chinese pharmaceutical company producing traditional Chinese medicines.
China Shineway Pharmaceutical Group Limited
A leading Chinese pharmaceutical company producing traditional Chinese medicines.
Chengdu Diao Pharmaceutical Group Co., Ltd.
Specializes in traditional Chinese medicine, including Zuo Gui Wan.
Chengdu Diao Pharmaceutical Group Co., Ltd.
Specializes in traditional Chinese medicine, including Zuo Gui Wan.
Guizhou Yibai Pharmaceutical Co., Ltd.
Specializes in traditional Chinese medicine, including Zuo Gui Wan.
Guizhou Yibai Pharmaceutical Co., Ltd.
Specializes in traditional Chinese medicine, including Zuo Gui Wan.
Beijing Holley-Cotec Pharmaceuticals Co., Ltd.
A Chinese pharmaceutical company focusing on traditional Chinese medicine products.
Beijing Holley-Cotec Pharmaceuticals Co., Ltd.
A Chinese pharmaceutical company focusing on traditional Chinese medicine products.
Renhe Pharmacy Group Co., Ltd.
A Chinese pharmaceutical company offering a variety of traditional Chinese medicines.
Renhe Pharmacy Group Co., Ltd.
A Chinese pharmaceutical company offering a variety of traditional Chinese medicines.
Taitong Pharmaceutical Co., Ltd.
A Chinese pharmaceutical company focused on traditional Chinese medicine products.
Taitong Pharmaceutical Co., Ltd.
A Chinese pharmaceutical company focused on traditional Chinese medicine products.
Lanzhou Foci Pharmaceutical Co., Ltd.
Specializes in the production of traditional Chinese medicines, including Zuo Gui Wan.
Lanzhou Foci Pharmaceutical Co., Ltd.
Specializes in the production of traditional Chinese medicines, including Zuo Gui Wan.
Kangmei Pharmaceutical Co., Ltd.
A major Chinese pharmaceutical company offering a range of traditional Chinese medicines.
Kangmei Pharmaceutical Co., Ltd.
A major Chinese pharmaceutical company offering a range of traditional Chinese medicines.
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
A renowned brand for traditional Chinese medicines, including donkey-hide gelatin.
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
A renowned brand for traditional Chinese medicines, including donkey-hide gelatin.
Beijing Tong Ren Tang Group
Tong Ren Tang is a centuries-old brand known for its traditional Chinese medicine, including its effective autumn pear syrup.
Beijing Tong Ren Tang Group
Tong Ren Tang is a centuries-old brand known for its traditional Chinese medicine, including its effective autumn pear syrup.
Harbin Pharmaceutical Group Co., Ltd.
Harbin Pharmaceutical Group Co., Ltd. ( hereinafter referred to as "Habin Pharmaceutical Co., Ltd." ) is a large enterprise group integrating pharmaceutical manufacturing, trade and scientific research. In June 1993, the company was listed on the Shanghai Stock Exchange (stock code "600664"). The company covers three core business segments of industrial manufacturing, commerce and GNC. It has 10 industrial enterprises including Harbin Pharmaceutical Sanjing, Harbin Pharmaceutical General Factory, Harbin Pharmaceutical Six Factory, and Harbin Pharmaceutical Shiyitang. Harbin Pharmaceutical Renmin Tongtai (listed company ) and Harbin Pharmaceutical Marketing two commercial distribution companies, and also has a pharmaceutical research institute with strong scientific research capabilities, focusing on innovative research and development in high-tech fields such as central nervous system, anti-tumor, cardiovascular and cerebrovascular drugs. Hayao Co., Ltd. has 1,816 drug approvals and 74 health food approvals. The leading products include calcium gluconate oral solution, zinc gluconate oral solution, amoxicillin capsules, Shuanghuanglian oral solution, prostadil injection, and pediatric aminophen yellow. Namin granules, Rasidipin tablets, ceftiam hydrochloride for injection, ibuprofen granules, Xingai Zhonggai brand high calcium tablets, etc. The company owns five trademarks: "Haya Medicine", "Three Essences", "Guizhong Gai", "Hutong" and "Shiyitang", with a brand value of more than 20 billion yuan. Integrity, professionalism, openness and inclusiveness, collaboration and responsibility, innovation and efficiency are the core values of corporate development. Harbin Pharmaceutical Co., Ltd. is an enterprise with relatively innovative capabilities and pioneering spirit. In the future, the company will coordinate the talent chain, industrial chain and capital chain, comprehensively build an open innovation ecosystem, constantly explore high-quality development paths, and continue to make efforts in many fields such as products, technology, R&D, intelligent manufacturing, business models, and management mechanisms. Breakthrough and transformation make Harbin Pharmaceutical a benchmark for Chinese national pharmaceutical companies that consumers, customers, employees and society are proud of.
Harbin Pharmaceutical Group Co., Ltd.
Harbin Pharmaceutical Group Co., Ltd. ( hereinafter referred to as "Habin Pharmaceutical Co., Ltd." ) is a large enterprise group integrating pharmaceutical manufacturing, trade and scientific research. In June 1993, the company was listed on the Shanghai Stock Exchange (stock code "600664"). The company covers three core business segments of industrial manufacturing, commerce and GNC. It has 10 industrial enterprises including Harbin Pharmaceutical Sanjing, Harbin Pharmaceutical General Factory, Harbin Pharmaceutical Six Factory, and Harbin Pharmaceutical Shiyitang. Harbin Pharmaceutical Renmin Tongtai (listed company ) and Harbin Pharmaceutical Marketing two commercial distribution companies, and also has a pharmaceutical research institute with strong scientific research capabilities, focusing on innovative research and development in high-tech fields such as central nervous system, anti-tumor, cardiovascular and cerebrovascular drugs. Hayao Co., Ltd. has 1,816 drug approvals and 74 health food approvals. The leading products include calcium gluconate oral solution, zinc gluconate oral solution, amoxicillin capsules, Shuanghuanglian oral solution, prostadil injection, and pediatric aminophen yellow. Namin granules, Rasidipin tablets, ceftiam hydrochloride for injection, ibuprofen granules, Xingai Zhonggai brand high calcium tablets, etc. The company owns five trademarks: "Haya Medicine", "Three Essences", "Guizhong Gai", "Hutong" and "Shiyitang", with a brand value of more than 20 billion yuan. Integrity, professionalism, openness and inclusiveness, collaboration and responsibility, innovation and efficiency are the core values of corporate development. Harbin Pharmaceutical Co., Ltd. is an enterprise with relatively innovative capabilities and pioneering spirit. In the future, the company will coordinate the talent chain, industrial chain and capital chain, comprehensively build an open innovation ecosystem, constantly explore high-quality development paths, and continue to make efforts in many fields such as products, technology, R&D, intelligent manufacturing, business models, and management mechanisms. Breakthrough and transformation make Harbin Pharmaceutical a benchmark for Chinese national pharmaceutical companies that consumers, customers, employees and society are proud of.
Jiuzhitang's predecessor, "Laojiuzhitang Pharmacy", originated in the seventh year of Shunzhi in the Qing Dynasty, that is, in 1650 AD. In 2000, Jiuzhitang was listed on the Shenzhen Stock Exchange with the stock code 000989. In September 2006, "Jiuzhitang" was recognized as a "Chinese time-honored brand" by the Ministry of Commerce; in June 2008, Jiuzhitang's traditional Chinese medicine culture was included in the national intangible cultural heritage. Protect the directory. Over the years, Jiuzhitang has always adhered to the patriotic sentiment of "Nine Provinces Helping Mutual and Zhilans Fragrance", innovating in inheritance and developing in innovation. It has now developed into more than 30 branches under its jurisdiction, with more than 500 chain stores, A modern large-scale pharmaceutical enterprise integrating production, sales, scientific research and health management. The company has a series of Chinese patent medicines, Guixiu Decoction tablets, biopharmaceuticals, and big health products, forming Shuxuetong Injection, Donkey Jack Buxue Granules, Liuwei Dihuang Pills, Donkey Jack, Angong Niuhuang Pills, Zuguang San, Bushen Guchi Pills, Nude flower purple bead tablets and Schikang are the core-driven development engines, covering various fields such as cardiovascular and cerebrovascular, kidney and blood, gynecology, gynecology and other fields, protecting public health in all aspects and throughout the life cycle. While stabilizing the development of its main business, Jiuzhitang actively developed a new chain clinic. Jiuzhitang Health Building located in Changsha was successfully approved as a demonstration base for traditional Chinese medicine health tourism, achieving a leap from focusing on pharmaceuticals to cultural heritage. Jiuzhitang implements the mission of "a hundred years of Jiuzhitang serving big health", adheres to the development concept of "combining inheritance and innovation", integrates traditional medicine and precision medicine, enters the fields of biomedicine and regenerative medicine, and is committed to preventing, treating, and rehabilitation. Each field provides accurate and effective services for the health management of the entire life cycle of human beings, and takes the big health field as the starting point and end point of Jiuzhitang in the future, polishes Jiuzhitang's century-old brand and leads the national health industry.
Jiuzhitang Co., Ltd.
Jiuzhitang's predecessor, "Laojiuzhitang Pharmacy", originated in the seventh year of Shunzhi in the Qing Dynasty, that is, in 1650 AD. In 2000, Jiuzhitang was listed on the Shenzhen Stock Exchange with the stock code 000989. In September 2006, "Jiuzhitang" was recognized as a "Chinese time-honored brand" by the Ministry of Commerce; in June 2008, Jiuzhitang's traditional Chinese medicine culture was included in the national intangible cultural heritage. Protect the directory. Over the years, Jiuzhitang has always adhered to the patriotic sentiment of "Nine Provinces Helping Mutual and Zhilans Fragrance", innovating in inheritance and developing in innovation. It has now developed into more than 30 branches under its jurisdiction, with more than 500 chain stores, A modern large-scale pharmaceutical enterprise integrating production, sales, scientific research and health management. The company has a series of Chinese patent medicines, Guixiu Decoction tablets, biopharmaceuticals, and big health products, forming Shuxuetong Injection, Donkey Jack Buxue Granules, Liuwei Dihuang Pills, Donkey Jack, Angong Niuhuang Pills, Zuguang San, Bushen Guchi Pills, Nude flower purple bead tablets and Schikang are the core-driven development engines, covering various fields such as cardiovascular and cerebrovascular, kidney and blood, gynecology, gynecology and other fields, protecting public health in all aspects and throughout the life cycle. While stabilizing the development of its main business, Jiuzhitang actively developed a new chain clinic. Jiuzhitang Health Building located in Changsha was successfully approved as a demonstration base for traditional Chinese medicine health tourism, achieving a leap from focusing on pharmaceuticals to cultural heritage. Jiuzhitang implements the mission of "a hundred years of Jiuzhitang serving big health", adheres to the development concept of "combining inheritance and innovation", integrates traditional medicine and precision medicine, enters the fields of biomedicine and regenerative medicine, and is committed to preventing, treating, and rehabilitation. Each field provides accurate and effective services for the health management of the entire life cycle of human beings, and takes the big health field as the starting point and end point of Jiuzhitang in the future, polishes Jiuzhitang's century-old brand and leads the national health industry.
